Mometasonfuroaat Glenmark (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasonfuroaat Glenmark, is a corticosteroid presented as a topical formulation for skin application. It is used to reduce inflammation and relieve symptoms in various dermatologic conditions affecting adults and children, including atopic dermatitis, psoriasis and seborrheic dermatitis.

GNH USA supplies Mometasonfuroaat Glenmark as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on timely delivery, comprehensive documentation and regulatory compliance for global distribution.

Mometasone furoate is a topical corticosteroid that modulates inflammatory pathways in skin disorders. - Atopic dermatitis: reduces erythema, itching and scaling, helping restore skin barrier function. - Psoriasis: diminishes plaque thickness and inflammation, improving lesion appearance. - Seborrheic dermatitis: alleviates redness and flaking on scalp and facial areas.

Topical application of mometasone furoate may be associated with local and systemic adverse reactions.

Common Side Effects: - Skin irritation: mild burning or stinging at the application site. - Dryness: localized skin dryness or scaling. - Pruritus: transient itching. - Erythema: mild redness. - Folliculitis: small pustules around hair follicles.

Serious or Rare Side Effects: - Skin atrophy: thinning of the epidermis with prolonged use. - Telangiectasia: visible small blood vessels. - Hypopigmentation: loss of skin colour. - Secondary infection: bacterial, fungal or viral infection of treated area. - Systemic effects: adrenal suppression with extensive application.

When using mometasone furoate, consider the following precautions to minimise risk. - Application area: limit to affected skin and avoid large surface areas. - Duration: use for the shortest period necessary; discontinue if no improvement within 2‑4 weeks. - Age restrictions: avoid use in infants under 2 years unless prescribed. - Concomitant therapy: do not combine with other potent topical steroids without medical guidance. - Occlusion: avoid covering treated skin with airtight dressings unless directed. - Store at below 25°C: keep in original container, protect from moisture and direct sunlight.

Mometasone furoate may interact with other agents; review the following categories.

Major Interactions (Avoid): - Systemic corticosteroids: increased risk of systemic side effects. - CYP3A4 inhibitors (e.g., ketoconazole): may raise local drug levels. - Antifungal agents applied to the same area: potential additive irritation. - Live vaccines: topical steroids may reduce local immune response.

Moderate Interactions (Monitor Closely): - Antihistamines: may mask early signs of irritation. - Topical NSAIDs: monitor for enhanced skin thinning. - Phototherapy: increased risk of skin atrophy when combined.